Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$CRL Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.03 down -102.83% YoY • Reported revenue of $1B down -2.72% YoY • Charles River Laboratories is increasing its 2026 revenue and non-GAAP earnings per share guidance, reflecting operational outperformance, while reducing GAAP earnings per share guidance due to net loss from divestitures.

Price since post

Full Details

Advertisement|Remove ads.